Caulfield, Timothy A., 1963-....
Timothy Caulfield juriste canadien
Caulfield, Timothy
Caulfield, Timothy, 1963-
VIAF ID: 18975252 (Personal)
Permalink: http://viaf.org/viaf/18975252
Preferred Forms
-
-
- 100 1 _ ‡a Caulfield, Timothy A. ‡d 1963-
- 100 1 _ ‡a Caulfield, Timothy A. ‡d 1963-
-
- 100 1 _ ‡a Caulfield, Timothy A., ‡d 1963-
-
-
-
- 100 1 _ ‡a Caulfield, Timothy A., ‡d 1963-....
-
- 100 0 _ ‡a Timothy Caulfield ‡c juriste canadien
4xx's: Alternate Name Forms (10)
5xx's: Related Names (4)
- 510 2 _ ‡a Commission sur l'avenir des soins de santé au Canada
- 510 2 _ ‡a Dalhousie University ‡b Faculty of Law
- 510 2 _ ‡a University of Alberta
- 510 2 _ ‡a University of Alberta.
Works
Title | Sources |
---|---|
Accountability in health care and legal approaches | |
The certainty illusion : essential things to know about the things you don't know | |
The commercialization of genetic research : ethical, legal, and policy issues | |
The cure for everything : untangling twisted messages about health, fitness, and happiness | |
Gwyneth Paltrows Netflix-show er infomercials for hendes pseudovidenskabelige forretning | |
Health care reform & the law in Canada : meeting the challenge | |
Health legislation trends in the English-speaking American region, 1997: | |
How do current common law principles impede or facilitate change? | |
Imagining Science : art, science, and social change | |
Is Gwyneth Paltrow wrong about everything? : how the famous sell us elixirs of health, beauty & happiness / Timothy Caulfield. | |
Is Gwyneth Paltrow wrong about everything? : when celebrity culture and science clash | |
Jetzt entspann dich mal! warum wir getrost aufhören können, Angst vor falschen Entscheidungen zu haben | |
The last straw : the impact of cost containment in health care on medical malpractice law. | |
Legal rights and human genetic material, 1996: | |
The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions | |
Media portrayal of conflicts of interest in herbal remedy clinical trials. | |
Nutrigenomics patents and commercialization: old wine in a new bottle? | |
On se calme! : comment faire face aux 1001 choix d'une seule journée | |
Patients' crowdfunding campaigns for alternative cancer treatments | |
Perceptions of promise : biotechnology, society, and art | |
Personal medicine--the new banking crisis | |
Physicians' liability and drug formulary restrictions. | |
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions | |
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism | |
Policy uncertainty, sequencing, and cell lines | |
Politics, prohibitions and the lost public perspective: a comment on Bill C-56: the Assisted Human Reproduction Act. | |
Popular representations of race: the news coverage of BiDil | |
The portrayal of organ donation on TikTok: A content analysis of popular English-language TikTok videos | |
Portrayal of umbilical cord blood research in the North American popular press: promise or hype? | |
Position statement on the provision and procurement of human eggs for stem cell research | |
Pragmatic clinical trials and the consent process | |
Professional regulation: a potentially valuable tool in responding to "stem cell tourism" | |
Promotion of Testing for Celiac Disease and the Gluten-Free Diet Among Complementary and Alternative Medicine Practitioners | |
Pseudoscience and COVID-19 - we've had enough already | |
Public health law and policy in Canada | |
Race and ancestry in biomedical research: exploring the challenges | |
Reconsenting paediatric research participants for use of identifying data | |
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate | |
Reflections on the gene patent war: the myriad battle, Sputnik and beyond | |
The regulation of science and the Charter of Rights: would a ban on non-reproductive human cloning unjustifiably violate freedom of expression? | |
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action | |
Relax. : a guide to everyday health decisions with more facts and less worry | |
Relax, dammit! | |
Relax, Dammit: A User's Guide to the Age of Anxiety | |
Relax! : feit en fictie achter al je dagelijkse beslissingen | |
Representing a "revolution": how the popular press has portrayed personalized medicine | |
Research ethics and the challenge of whole-genome sequencing | |
Research ethics and the role of the professional bodies: a view from Canada | |
Restricting marketing to children: consensus on policy interventions to address obesity | |
Role and reality: technology transfer at Canadian universities | |
SafetyNET: An interdisciplinary research program to support a safety culture for spinal manipulation therapy | |
Science and regulation. Regulating direct-to-consumer personal genome testing | |
Science communication reconsidered | |
SCIENTIFIC COMMUNITY. Confronting stem cell hype | |
Scientific freedom and research cloning: can a ban be justified? | |
Scientists' perspectives on consent in the context of biobanking research | |
Selling falsehoods? A cross-sectional study of Canadian naturopathy, homeopathy, chiropractic and acupuncture clinic website claims relating to allergy and asthma | |
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines | |
Should we call it fraud? | |
Societal values in the allocation of healthcare resources: is it all about the health gain? | |
Somatic cell nuclear transfer--how science outpaces the law | |
Spinning the Genome: Why Science Hype Matters | |
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine | |
Stem cell hype: media portrayal of therapy translation | |
The stem cell market and policy options: a call for clarity. | |
The stem cell research environment: a patchwork of patchworks | |
Stem cell research ethics: consensus statement on emerging issues | |
Stem cell research, scientific freedom and the commodification concern | |
Stem cell tourism and Canadian family physicians. | |
Stem cell tourism and doctors' duties to minors--a view from Canada. | |
Stem cells, politics and the progress paradigm | |
Stjerneforsker: Derfor hopper vi på Gwyneth Paltrows sundhedsshow | |
The "subluxation" issue: an analysis of chiropractic clinic websites | |
Supported by science?: what canadian naturopaths advertise to the public | |
Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers | |
That personal touch. | |
Le tourisme des cellules souches et les médecins de famille canadiens | |
Tracing the use and source of racial terminology in representations of genetic research | |
Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers | |
Trust, patents and public perceptions: the governance of controversial biotechnology research | |
Variation in Ethics Review of Multi-Site Research Initiatives | |
Variations and voids: the regulation of human cloning around the world | |
Võta vabalt! : ärevuse ajastu käsiraamat | |
What's missing? Discussing stem cell translational research in educational information on stem cell "tourism". | |
Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate | |
Your day, your way : the fact and fiction behind your daily decisions |